CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Paul D. Baxter |
| Publication date | May 10, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |